Literature DB >> 28620103

Pre-PMF emerging as important subgroup of MPN.

Heinz Gisslinger1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28620103     DOI： 10.1182/blood-2017-04-777805

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037

2.  Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data.

Authors:  Martin Schalling; Andreas Gleiss; Bettina Gisslinger; Albert Wölfler; Veronika Buxhofer-Ausch; Georg Jeryczynski; Maria-Theresa Krauth; Ingrid Simonitsch-Klupp; Christine Beham-Schmid; Jürgen Thiele; Heinz Gisslinger
Journal:  Blood Cancer J       Date:  2017-12-13       Impact factor: 11.037

Review 3.  Prefibrotic myelofibrosis: treatment algorithm 2018.

Authors:  Guido Finazzi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

Review 4.  The new WHO classification for essential thrombocythemia calls for revision of available evidences.

Authors:  Tiziano Barbui; Jürgen Thiele; Alberto Ferrari; Alessandro M Vannucchi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2020-02-25       Impact factor: 11.037

5.  A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis.

Authors:  Alessandra Carobbio; Paola Guglielmelli; Elisa Rumi; Chiara Cavalloni; Valerio De Stefano; Silvia Betti; Alessandro Rambaldi; Maria Chiara Finazzi; Juergen Thiele; Alessandro M Vannucchi; Ayalew Tefferi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2020-10-14       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.